Skip to content
Senate to vote on drug price controls legislation
The Senate is about to vote on a bill that would put limits on how much drugs can cost. According to a new Vital […]
Senate to vote on drug price controls legislation Read More »
BIO’s View
Get BIO’s view on everything from health care to biofuels and the bioeconomy. The below articles include BIO statements, opinion, and calls to action, as well as articles and op-eds written by BIO leadership.
Drug price control plan will disrupt biotech ecosystem, expert says
Proposed drug price controls will disrupt the vibrant US biotech ecosystem, according to Vital Transformation CEO Duane Schulthess. He spoke during an online briefing
Drug price control plan will disrupt biotech ecosystem, expert says Read More »
The case of the EU and Japan: How price controls hurt biotech innovation
In light of the Senate’s current push for medication price limits, research analyzes the EU’s and Japan’s experiences to see how rapidly price controls
The case of the EU and Japan: How price controls hurt biotech innovation Read More »
McKalip, USTR nominee: Enforcing USMCA provisions on biotech a top priority
The Senate Finance Committee held a hearing yesterday on Doug McKalip’s nomination to the position of Chief Agricultural Negotiator in the Office of the
McKalip, USTR nominee: Enforcing USMCA provisions on biotech a top priority Read More »
Drug price controls will destroy drug development, says study
According to new research published today by Vital Transformation, if drug price controls under consideration in the Senate had been in place over the
Drug price controls will destroy drug development, says study Read More »
Funding BARDA is key to pandemic preparedness – here’s why
We have to ensure the Biomedical Advanced Research and Development Authority (BARDA) “is properly funded so that it can continue to strengthen our preparedness
Funding BARDA is key to pandemic preparedness – here’s why Read More »
Biopharma industry launches Berlin Declaration for ‘equitable pandemic preparedness and response’
This week, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) announced the “Berlin Declaration,” a framework to collaborate with the G7 and G20
AMR could be worse than the COVID-19 pandemic, experts say
According to a study published earlier this year in The Lancet, antimicrobial-resistant infections have become a leading global cause of mortality. The study showed
AMR could be worse than the COVID-19 pandemic, experts say Read More »
House passes Ag-FDA spending bill that boosts biotech
The House of Representatives passed legislation on Wednesday, July 20, that would give the U.S. Food and Drug Administration (FDA) the direction and resources
House passes Ag-FDA spending bill that boosts biotech Read More »
BLS: Inflation is way up – but drug prices are not
The most recent data from the Bureau of Labor Statistics (BLS), which came out last week, shows that drug prices are rising more slowly
BLS: Inflation is way up – but drug prices are not Read More »